IT1296914B1 - Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera - Google Patents
Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barrieraInfo
- Publication number
- IT1296914B1 IT1296914B1 IT97MI002663A ITMI972663A IT1296914B1 IT 1296914 B1 IT1296914 B1 IT 1296914B1 IT 97MI002663 A IT97MI002663 A IT 97MI002663A IT MI972663 A ITMI972663 A IT MI972663A IT 1296914 B1 IT1296914 B1 IT 1296914B1
- Authority
- IT
- Italy
- Prior art keywords
- overcoming
- barrier
- pharmaceutical composition
- composition including
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI002663A IT1296914B1 (it) | 1997-12-01 | 1997-12-01 | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
EP98965704A EP1071408B1 (en) | 1997-12-01 | 1998-11-27 | Microparticles for drug delivery across mucosa and the blood-brain barrier |
US09/555,828 US6419949B1 (en) | 1997-12-01 | 1998-11-27 | Microparticles for drug delivery across mucosa and the blood-brain barrier |
PCT/EP1998/007664 WO1999027918A1 (en) | 1997-12-01 | 1998-11-27 | Microparticles for drug delivery across mucosa and the blood-brain barrier |
AT98965704T ATE303799T1 (de) | 1997-12-01 | 1998-11-27 | Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke |
AU21551/99A AU2155199A (en) | 1997-12-01 | 1998-11-27 | Microparticles for drug delivery across mucosa and the blood-brain barrier |
DE69831511T DE69831511T2 (de) | 1997-12-01 | 1998-11-27 | Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke |
ES98965704T ES2247736T3 (es) | 1997-12-01 | 1998-11-27 | Microparticulas para el transporte de sustancias farmaceuticas a traves de la mucosa y la barrera hematoencefalica. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT97MI002663A IT1296914B1 (it) | 1997-12-01 | 1997-12-01 | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI972663A1 ITMI972663A1 (it) | 1999-06-01 |
IT1296914B1 true IT1296914B1 (it) | 1999-08-03 |
Family
ID=11378297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT97MI002663A IT1296914B1 (it) | 1997-12-01 | 1997-12-01 | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
Country Status (8)
Country | Link |
---|---|
US (1) | US6419949B1 (it) |
EP (1) | EP1071408B1 (it) |
AT (1) | ATE303799T1 (it) |
AU (1) | AU2155199A (it) |
DE (1) | DE69831511T2 (it) |
ES (1) | ES2247736T3 (it) |
IT (1) | IT1296914B1 (it) |
WO (1) | WO1999027918A1 (it) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1296914B1 (it) | 1997-12-01 | 1999-08-03 | Maria Rosa Gasco | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
US7153525B1 (en) | 2000-03-22 | 2006-12-26 | The University Of Kentucky Research Foundation | Microemulsions as precursors to solid nanoparticles |
AU784191B2 (en) * | 2000-04-11 | 2006-02-16 | Ibergesfer, S.L. | Structure for a washbasin |
DE60130791T2 (de) * | 2000-12-27 | 2008-07-17 | Ares Trading S.A. | Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation |
US7763663B2 (en) | 2001-12-19 | 2010-07-27 | University Of Massachusetts | Polysaccharide-containing block copolymer particles and uses thereof |
US20040009213A1 (en) * | 2002-03-13 | 2004-01-15 | Thomas Skold | Water-based delivery systems |
CA2486967A1 (en) * | 2002-05-24 | 2003-12-04 | Neopharm, Inc. | Cardiolipin compositions their methods of preparation and use |
EA200401565A1 (ru) * | 2002-05-24 | 2005-04-28 | Неофарм, Инк. | Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты) |
US20050277611A1 (en) * | 2002-10-16 | 2005-12-15 | Neopharm, Inc. | Cationic cardiolipin analoges and its use thereof |
ITMI20022323A1 (it) * | 2002-10-31 | 2004-05-01 | Maria Rosa Gasco | Composizioni farmaceutiche atte al trattamento di malattie oftalmiche. |
US20050101605A1 (en) * | 2003-11-07 | 2005-05-12 | Ahmed Salah U. | Oral liquid formulations of methotrexate |
CA2563533C (en) * | 2004-04-15 | 2013-10-01 | Shmuel A. Ben-Sasson | Compositions capable of facilitating penetration across a biological barrier |
US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
ITMI20041151A1 (it) * | 2004-06-09 | 2004-09-09 | Maria Rosa Gasco | Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso |
US20090180964A1 (en) * | 2005-06-24 | 2009-07-16 | Rao Papineni | Transmucosal delivery of optical, spect, multimodal,drug or biological cargo laden nanoparticle(s) in small animals or humans |
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
US20070154403A1 (en) * | 2006-01-05 | 2007-07-05 | Thomas Skold | Oral, Pulmonary and Transmucosal Delivery Composition |
US7914988B1 (en) | 2006-03-31 | 2011-03-29 | Illumina, Inc. | Gene expression profiles to predict relapse of prostate cancer |
EP1867323A1 (en) * | 2006-06-13 | 2007-12-19 | Farmatron Ltd. | Pharmaceutical compositions with biological barriers permeation enhancing properties |
JP2010526636A (ja) * | 2007-05-16 | 2010-08-05 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | 血液脳関門破壊の評価 |
EP2249817B8 (en) * | 2008-02-18 | 2012-03-21 | Csir | Nanoparticle carriers for drug administration and process for producing same |
EP2123262A1 (en) | 2008-05-20 | 2009-11-25 | Consorzio per il Centro di Biomedica Moleculare Scrl | Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier |
CA2730760A1 (en) * | 2008-07-16 | 2010-01-21 | Surmodics Pharmaceuticals, Inc. | Process for preparing microparticles containing bioactive peptides |
MX2011002836A (es) | 2008-09-17 | 2011-04-28 | Chiasma Inc | Composiciones farmaceúticas y métodos de administración relacionados. |
EP2467060A2 (en) | 2009-08-18 | 2012-06-27 | Ben Gurion University Of The Negev Research And Development Authority | System and method for analyzing imaging data |
WO2013057697A1 (en) | 2011-10-19 | 2013-04-25 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Magnetic resonance maps for analyzing tissue |
EP2645099A1 (en) * | 2012-03-30 | 2013-10-02 | Phares Pharmaceutical Research N.V. | Biorelevant compositions |
US10809323B2 (en) | 2013-04-24 | 2020-10-20 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Magnetic resonance maps for analyzing tissue |
JP6091721B2 (ja) * | 2014-12-19 | 2017-03-08 | 積水化学工業株式会社 | 製剤 |
EP3247333B1 (en) | 2015-01-20 | 2021-07-21 | Tetraderm Group LLC | Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration |
CA2975599A1 (en) | 2015-02-03 | 2016-08-11 | Chiasma Inc. | Method of treating diseases |
CN117731591A (zh) | 2016-11-21 | 2024-03-22 | 艾里奥治疗公司 | 大试剂的透皮递送 |
JP7219344B2 (ja) * | 2019-01-07 | 2023-02-07 | プサン ナショナル ユニバーシティ インダストリー-ユニバーシティ コーポレーション ファウンデーション | 血液脳関門の透過性を増進させるw/o/w型トリオレインエマルジョンを利用した薬物伝達プラットホーム |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3421468A1 (de) | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
US5250236A (en) * | 1991-08-05 | 1993-10-05 | Gasco Maria R | Method for producing solid lipid microspheres having a narrow size distribution |
DE4131562A1 (de) * | 1991-09-18 | 1993-03-25 | Medac Klinische Spezialpraep | Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln) |
DE4327063A1 (de) * | 1993-08-12 | 1995-02-16 | Kirsten Dr Westesen | Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften |
US5858398A (en) * | 1994-11-03 | 1999-01-12 | Isomed Inc. | Microparticular pharmaceutical compositions |
IT1292142B1 (it) | 1997-06-12 | 1999-01-25 | Maria Rosa Gasco | Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale |
IT1296914B1 (it) | 1997-12-01 | 1999-08-03 | Maria Rosa Gasco | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
-
1997
- 1997-12-01 IT IT97MI002663A patent/IT1296914B1/it active IP Right Grant
-
1998
- 1998-11-27 AU AU21551/99A patent/AU2155199A/en not_active Abandoned
- 1998-11-27 DE DE69831511T patent/DE69831511T2/de not_active Expired - Lifetime
- 1998-11-27 AT AT98965704T patent/ATE303799T1/de not_active IP Right Cessation
- 1998-11-27 WO PCT/EP1998/007664 patent/WO1999027918A1/en active IP Right Grant
- 1998-11-27 ES ES98965704T patent/ES2247736T3/es not_active Expired - Lifetime
- 1998-11-27 EP EP98965704A patent/EP1071408B1/en not_active Expired - Lifetime
- 1998-11-27 US US09/555,828 patent/US6419949B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1071408B1 (en) | 2005-09-07 |
ITMI972663A1 (it) | 1999-06-01 |
US6419949B1 (en) | 2002-07-16 |
DE69831511D1 (de) | 2005-10-13 |
AU2155199A (en) | 1999-06-16 |
EP1071408A1 (en) | 2001-01-31 |
ES2247736T3 (es) | 2006-03-01 |
DE69831511T2 (de) | 2006-06-14 |
ATE303799T1 (de) | 2005-09-15 |
WO1999027918A1 (en) | 1999-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1296914B1 (it) | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera | |
DK1553927T3 (da) | Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger | |
AR020288A1 (es) | Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado. | |
ES2187201T3 (es) | Empleo de esteroles y de esterolesteres a nanoescala. | |
BR0100424A (pt) | Nanoemulsão óleo-em-água que contém lipìdios anfìfilos e um polìmero não iÈnico, composição cosmética de uso tópico, suas utilizações, processo de tratamento não terapêutico e processo para espessar as nanoemulsões óleo-em -água | |
AU4151099A (en) | Cosmetic or dermopharmaceutical composition in the form of beads and methods forpreparing same | |
ES2178187T3 (es) | Sistema finamente dispersos de tipo agua en aceite sin emulsionantes. | |
EP2298299A3 (en) | O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders | |
NO961363D0 (no) | Nytt emulsjonspreparat | |
AR030862A1 (es) | Formulaciones medicinales en aerosol | |
CO5611097A2 (es) | Tableta farmaceutica | |
AR043272A1 (es) | Una microparticula recubierta con una sustancia lipofilica que contiene una droga proteica o antigeno y formulaciones que la comprenden | |
IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
WO2001005362A3 (de) | Emulgatorfreie feindisperse systeme vom typ wasser-in-öl | |
ES2231176T3 (es) | Uso de beta-(1,3)-glucanos nanometricos hidrosolubles. | |
RS50310B (sr) | Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži | |
ATE331528T1 (de) | Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden. | |
RS50345B (sr) | Vodena farmaceutska kompozicija koja sadrži ciklesonid | |
FR2788980B1 (fr) | Nanoemulsion a base d'alkenyl succinates alkoxyles ou d'alkenyl succinates de glucose alkoxyles, et ses utilisations dans les domaines cosmetique, dermatologique, ophtalmologique et/ou pharmaceutique | |
MA26788A1 (fr) | COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION | |
DE60121293D1 (de) | Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen | |
FR2817257B1 (fr) | Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant | |
BR9811994A (pt) | Suspensão farmacêutica compreendendo hemi-hidrato de nevirapina | |
BR0011864A (pt) | Formulações farmacêuticas | |
FR2786104B1 (fr) | Inhibiteurs de l'activation de nf-kb, et leurs utilisations pharmaceutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |